TY  - JOUR
AU  - Gómez-Aparicio, Maria Antonia
AU  - López-Campos, Fernando
AU  - Pelari-Mici, Lira
AU  - Buchser, David
AU  - Pastor, Jorge
AU  - Maldonado, Xavier
AU  - Zafra, Juan
AU  - Tree, Alison C
AU  - Bultijnck, Renée
AU  - Sargos, Paul
AU  - Ost, Piet
AU  - Couñago, Felipe
PY  - 2022
DO  - 10.31083/j.fbl2701034
UR  - http://hdl.handle.net/10668/21809
T2  - Frontiers in bioscience (Landmark edition)
AB  - Prostate cancer is the most frequent genitourinary tumor worldwide. Maintaining an optimum bone health throughout the natural course of prostate cancer is an important aspect in the management of this disease, particularly in this at risk population...
LA  - en
KW  - Bisphosphonates
KW  - Bone health
KW  - Denosumab
KW  - Osteoporosis
KW  - Prostate cancer
KW  - Skeletal-related events
KW  - Aged
KW  - Androgen Antagonists
KW  - Bone Density
KW  - Bone Neoplasms
KW  - Diphosphonates
KW  - Humans
KW  - Male
KW  - Prostatic Neoplasms
TI  - Bone health and therapeutic agents in advanced prostate cancer.
TY  - research article
VL  - 27
ER  -